Quarterly report [Sections 13 or 15(d)]

Insider Trading Arrangements

v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Dr. Theodore Tewksbury [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement On May 30, 2025, Dr. Theodore Tewksbury, a director of the Company, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 12,141 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until August 21, 2026, or earlier if all transactions under the trading arrangement are completed.
Name Dr. Theodore Tewksbury
Title director
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 30, 2025
Expiration Date August 21, 2026
Arrangement Duration 448 days
Aggregate Available 12,141